1. Role of Checkpoint Inhibition in Localized Bladder Cancer
Noah M. Hahn, Andrea Necchi, Yohann Loriot, Thomas Powles, Elizabeth R. Plimack, Guru Sonpavde, Morgan Roupret, Ashish M. Kamat 
European Urology Oncology 
Volume 1, Issue 3, Pages (August 2018)
DOI: /j.euo
Copyright © Terms and Conditions

2. Fig. 1
CONSORT diagram of the inclusion and exclusion process for articles. CPI=checkpoint inhibitor.
European Urology Oncology 2018 1, DOI: ( /j.euo )
Copyright © Terms and Conditions

3. Fig. 2
Immunocompetent preclinical model systems for investigation of checkpoint inhibitors for localized bladder cancer. (A) BBN carcinogen-induced murine model. (B) MNU carcinogen-induced rat model. (C) MB49 syngeneic orthotopic murine model. BBN=N-butyl-N-(4-hydroxybutyl)nitrosamine; MNU=N-methyl-N-nitrosurea.
European Urology Oncology 2018 1, DOI: ( /j.euo )
Copyright © Terms and Conditions